Banner: BENLYSTA Homepage

"Sorry, Lupus.
You aren't ruining my recipe today."


Actual patient
receiving BENLYSTA

When you’re ready for something more, BENLYSTA may help.

Learn how.



BENLYSTA is a prescription medicine for patients with active systemic lupus erythematosus (SLE or lupus) receiving other lupus medicines. Intravenous dosing of BENLYSTA is approved for patients 5 years and older, and subcutaneous dosing is only approved for adults. It is not known if BENLYSTA is safe and effective in people with severe active lupus nephritis or severe active central nervous system lupus.

A site built for you

We understand what it’s like to live with lupus. We also realize that today we face many challenges. We are here to help. On this website, you will find information — from daily tips to what to expect during treatment with BENLYSTA. Take a little time to explore all we have to offer.
Learn About Taking Benlysta At Home

Designed for lupus

BENLYSTA is the first and only approved biologic designed for lupus in 50 years. It has been prescribed in over 58,000 adult patients since it was approved by the FDA for adults in 2011.* 

The IV formulation gained approval in 2019 for use in children 5 years and older.


* Source: Symphony Health, PayerSource, March 2011 to December 2018. Claims data based upon total unique number of patients who had at least one claim for BENLYSTA in the US only.


Understanding Lupus

Coping with lupus can be tough — physically, emotionally, and socially. Find resources to help you make your experiences about so much more than lupus.

Learn more


What kind of medicine is BENLYSTA?

BENLYSTA is a biologic therapy, not a steroid. It is taken in addition to your other lupus medications and is available to adult patients in three options and to children (ages 5 years and older) in one option:

  • an autoinjector you self-inject (for adults)

  • a prefilled syringe you self-inject (for adults) 

  • an intravenous (IV) infusion a healthcare provider administers (for adults and children ≥5 years old)

Image: Patient with Horse
Actual patient
receiving BENLYSTA

The Benefits of BENLYSTA

Adult Patients

In studies used in the approval of BENLYSTA,* when added to other medicines commonly used to treat lupus, compared to other lupus medicines alone, BENLYSTA has demonstrated:


Superior reduction in disease activity
Mainly due to improvements in the immune system, muscles, mouth, joints and skin


Superior reduction in the chance of severe flares

Reduction in the chance of severe flares occurred in two of the three studies†


Reduction in steroid dose‡

By 25% or more (to a daily dose of 7.5 mg or less) during Weeks 40-52, in patients receiving 7.5 mg or higher daily doses of steroid at the start of the study


* BLISS-52, BLISS-76, and BLISS-SC.

† A superior reduction in the chance of severe flares did not occur in the BLISS-76 trial.

‡ A numerical reduction in daily steroid dose was observed, but this difference was not big enough for researchers to be sure that BENLYSTA was better than the placebo when added to patients’ current lupus medicine(s).

Your results may vary.

Pediatric Patients (5 years and above)

When added to other medicines commonly used to treat lupus, compared to those medicines alone, BENLYSTA IV has been observed to§


Reduce lupus disease activity

Reduce the chance of severe flares

§Because lupus doesn’t occur in children very often, the pediatric study had a much smaller number of patients than the adult studies of BENLYSTA. The study in children was still able to support that BENLYSTA worked, with results similar to those from the adult studies. Due to the small size of the study, however, there was no way to confirm the effect or the consistency of the results.

Please note that these are findings based upon a study in pediatric patients.
Your child’s individual results may vary.
Learn about Benlysta


When we say that "BENLYSTA Cares," what does that really mean?

Whether you're just getting started on BENLYSTA or you've been taking it for a while, we offer resources created with you in mind.

 Nurses from BENLYSTA Cares do not give medical advice. They are only able to answer questions about BENLYSTA. These may include help with self-injections, guidance for getting BENLYSTA, answers about the co-pay program, and other general information. They will direct you to your healthcare provider for answers to other types of questions.


Icon: More Information

Ready for more?

As you and your doctor consider BENLYSTA, it’s natural to have questions. To learn more about how BENLYSTA works, understand information about ways to get your medicine, hear from others like you, and more, request our free BENLYSTA Information Kit.

Image: Group Playing Music
Actual patient
receiving BENLYSTA

Frequently Asked Questions

  • What are the common symptoms of lupus?

    Since SLE can affect many different parts of the body, it can cause a lot of different symptoms, and these symptoms may come and go. Also, symptoms may vary between one patient to the next.

    The most common signs and symptoms of lupus include fatigue (feeling tired often), fever, joint pain, stiffness and swelling, butterfly-shaped rash on the cheeks and bridge of the nose or rashes elsewhere on the body, sun sensitivity, fingers and toes that turn white or blue when exposed to cold or during stressful periods (Raynaud's phenomenon), shortness of breath, chest pain, dry eyes, headaches, and confusion and memory loss. Please note that this is not a complete list of all possible lupus symptoms. Talk to your healthcare provider to discuss your symptoms.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • What is systemic lupus erythematosus (SLE)?

    Lupus is a systemic autoimmune disease caused by your body's immune system attacking your own tissues and organs. Inflammation caused by lupus can affect many different body systems, including your joints, skin, kidneys, blood cells, brain, heart, and lungs.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • How does BENLYSTA work?

    In many patients with lupus, certain white blood cells called autoreactive B cells (cells that react against the body) stay in the body longer than they should. 

    One of the important proteins for the growth of these B cells is called B-lymphocyte stimulator, or BLyS. BENLYSTA works by binding to BLyS. When BENLYSTA is attached to BLyS, BLyS can no longer bind to and stimulate the autoreactive B cells.


    Get more information on how BENLYSTA works

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.